Drugs Made In America Acquisition II Corp Right
DMIIR
57 hedge funds and large institutions have $3.25M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
21% more funds holding
Funds holding: 47 → 57 (+10)
28% less capital invested
Capital invested by funds: $4.53M → $3.25M (-$1.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$307K |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$227K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$121K |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$104K |
| 5 |
MCS
Mercuria Capital Strategies
Houston,
Texas
|
+$85.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$290K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$30K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$17K |
| 4 |
QL
Quarry LP
New York
|
-$11.3K |
| 5 |
HCI
Harraden Circle Investments
New York
|
-$7K |
DMIIR Hedge Fund Activity: Q1 2026 in Review
57 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q1 2026, worth a combined $3.25M — down 28% from $4.53M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new DMIIR positions and 4 closed out — a net gain of 10 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was MMCAP International, opening a new position worth an estimated $307K. The largest seller was First Trust Capital Management, exiting entirely with an estimated $290K sold.
- 57 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q1 2026, up from 47 in Q4 2025.
- Funds reported $3.25M of Drugs Made In America Acquisition II Corp Right stock for Q1 2026, down 28% quarter-over-quarter.
- 14 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q1 2026 and 4 closed out, a net change of +10 holders.
- The largest Drugs Made In America Acquisition II Corp Right buyer in Q1 2026 was MMCAP International, an estimated $307K added.
- The largest Drugs Made In America Acquisition II Corp Right seller in Q1 2026 was First Trust Capital Management, an estimated $290K sold.
Based on aggregated 13F filings for Q1 2026.